Hi Tech Pharmacal Co. (HITK) Tops Q3 Views
Tweet
Share
E-mailGet Alerts HITK Hot Sheet
Join SI Premium – FREE
Hi Tech Pharmacal Co. (NASDAQ: HITK) reported Q3 EPS of $0.79, $0.16 better than the analyst estimate of $0.63. Revenue for the quarter came in at $50 million versus the consensus estimate of $45.33 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Jernigan Capital (JCAP) Tops Q2 EPS by 5c
- Lument Finance Trust (LFT) Misses Q2 EPS by 17c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
